JACC: Cardiovascular Imaging now abstracted and indexed by Thomson Reuters

April 23, 2010

New York, NY, 23 April, 2010 -- The American College of Cardiology and Elsevier are proud to announce that JACC: Cardiovascular Imaging has been accepted for coverage by Thomson Reuters (formerly Thomson Scientific/ISI) abstracting and indexing services, including the Journal Citation Reports®. The Journal will receive its first impact factor in 2011.

"The Editorial Board and the American College of Cardiology are extremely pleased that the JACC: Cardiovascular Imaging has been accepted by Thomson Reuters," commented Editor-in-Chief Jagat Narula, MD, PhD, FACC. "This coverage will help to further increase dissemination of the journal's content to support our mission to present new knowledge in integrated imaging to enhance patient care."

Abstracting and indexing will begin with Volume 1:1 (2008) in Science Citation Index Expanded (also known as SciSearch®), Social Sciences Citation Index®, Current Contents®/Clinical Medicine and Journal Citation Reports/Science Edition.

JACC: Cardiovascular Imaging publishes papers with direct relevance to patient care and addresses current issues impacting cardiovascular imaging. The editorial board actively encourages submission of original research articles on noninvasive and invasive imaging techniques, including echocardiography (surface, invasive, and interventional), CT, CMR (including spectroscopy), nuclear (including PET), optical imaging, and cine-angiography; advances in basic science and molecular imaging that are likely to substantially influence the clinical practice of medicine in the next decade.

"Coverage by Thomson Reuters clearly acknowledges the high-quality, significant work published in the journal and the continuing efforts of the highly-respected editors, reviewers and the ACC. We at Elsevier would like to thank them all for their contribution to this excellent achievement," stated Elsevier's Cynthia Baudendistel, Executive Publisher, Elsevier.
-end-
About JACC: Cardiovascular Imaging

JACC: Cardiovascular Imaging provides readers with a broad, balanced view of all aspects of cardiovascular imaging. With a circulation of over 13,000, JACC: Cardiovascular Imaging includes original clinical research on non-invasive and invasive imaging techniques including echocardiography, CT, CMR, nuclear, optical imaging, and cine-angiography. Advances in basic science and molecular imaging which are likely to substantially influence the clinical practice of medicine in the next decade (in diagnostic performance, understanding of the athogenetic basis of the disease, and therapy) are also featured. Additional content emphasizes imaging for the practicing cardiologist, advocacy and practice management, and state-of-the-art reviews.

About The American College of Cardiology

The ACC is the world's largest cardiology society with 37,000 members. The College is a leader in the formulation of health policy, standards and guidelines, and is a staunch supporter of cardiovascular research. The ACC also bestows the credential Fellow of the American College of Cardiology upon physicians who meet its stringent qualifications, provides professional education and operates national registries for the measurement and improvement of quality care.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including the Lancet (www.thelancet.com) and Cell (www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com), Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and Nursing Consult (www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (www.scival.com) and MEDai's Pinpoint Review (www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading publisher and information provider. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Elsevier

Related Molecular Imaging Articles from Brightsurf:

New technique offers higher resolution molecular imaging and analysis
The new approach from Northwestern Engineering could help researchers understand more complicated biomolecular interactions and characterize cells and diseases at the single-molecule level.

Molecular imaging offers insight into therapy outcomes for neuroendocrine tumor patients
A new proof-of-concept study published in the May issue of The Journal of Nuclear Medicine has demonstrated that molecular imaging can be used for identifying early response to 177Lu-DOTATATE treatment in neuroendocrine tumor patients.

Non-invasive imaging method spots cancer at the molecular level
Researchers for the first time have combined a powerful microscopy technique with automated image analysis algorithms to distinguish between healthy and metastatic cancerous tissue without relying on invasive biopsies or the use of a contrast dye.

Molecular imaging suggests smokers may have impaired neuroimmune function
Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNM MI) shows preliminary evidence that tobacco smokers may have reduced neuroimmune function compared with nonsmokers.

Novel noninvasive molecular imaging for monitoring rheumatoid arthritis
A first-in-human Phase 1/Phase II study demonstrates that intravenous administration of the radiopharmaceutical imaging agent technetium-99m (99mTc) tilmanocept promises to be a safe, well-tolerated, noninvasive means of monitoring rheumatoid arthritis disease activity.

Improving molecular imaging using a deep learning approach
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed using a new deep learning approach to image reconstruction developed by researchers at Rensselaer Polytechnic Institute.

Nanoplatform developed with three molecular imaging modalities for tumor diagnosis
Nanotechnology and biotechnology are bringing us increasingly closer to personalised cancer treatment.

Study suggests molecular imaging strategy for determining molecular classifications of NSCLC
Recent findings suggest a novel positron emission tomography (PET) imaging approach determining epidermal growth factor receptor (EGFR) mutation status for improved lung cancer patient management.

New imaging technique able to watch molecular dynamics of neurodegenerative diseases
Researchers have developed a fast and practical molecular-scale imaging technique that could let scientists view never-before-seen dynamics of biological processes involved in neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis.

Combined optical and molecular imaging could guide breast-conserving surgery
Breast-conserving surgery is the primary treatment for early-stage breast cancer, but more accurate techniques are needed to assess resection margins during surgery to avoid the need for follow-up surgeries.

Read More: Molecular Imaging News and Molecular Imaging Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.